Basics Codexis, Inc. Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels. IPO Date: April 22, 2010 Sector: Healthcare Industry: Biotech Market Cap: $176.44M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 2.77% Avg Daily Range (30 D): $0.10 | 4.00% Avg Daily Range (90 D): $0.13 | 3.56% Institutional Daily Volume Avg Daily Volume: .31M Avg Daily Volume (30 D): .8M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 120 Avg Trade Size (Sh.) (90 D): 113 Institutional Trades Total Inst.Trades: 1,238 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $.79M Avg Inst. Trade (90 D): $2.13M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.29M Avg Closing Trade (30 D): $.79M Avg Closing Trade (90 D): $2.49M Avg Closing Volume: 89.78K         News Apr 9, 2025 @ 9:00 PM Codexis Announces Byron Dorgan to Retire from Boar... Source: N/A Feb 20, 2025 @ 3:00 PM Specialty Enzymes Market to Expand at 7.5% CAGR, R... Source: Sns Insider Dec 4, 2024 @ 6:00 PM Global Artificial Sweeteners Market to Observe Gro... Source: Delveinsight Jul 1, 2024 @ 8:05 PM Codexis Finalizes Purchase Agreement with Crosswal... Source: Codexis, Inc. May 22, 2024 @ 8:25 PM Codexis to Participate in Jefferies Global Healthc... Source: Codexis, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.88 $-.29 $-.32 Diluted EPS $-.88 $-.29 $-.32 Revenue $ 64.45M $ 12.83M $ 7.98M Gross Profit $ 48.95M $ 8.52M $ 4.52M Net Income / Loss $ -62.09M $ -20.64M $ -22.76M Operating Income / Loss $ -50.9M $ -16.56M $ -22.73M Cost of Revenue $ 15.5M $ 4.32M $ 3.46M Net Cash Flow $ -37.6M $ 18.85M $ -39.45M PE Ratio